About Calcipotriol Monohydrate
Product Details: Packaging Size 25 kg
Calcipotriol (hydrate) is a low-calcemic vitamin D receptor (VDR) agonist. Calcipotriol (hydrate) is about 200 times less potent in its effects on calcium metabolism than vitamin D (1,25[OH]D3).Binding of calcipotriol (hydrate) to the VDR increases AP-1, a transcription factor important for keratinocyte differentiation, and reduces expression of JunB protein, a transcriptional activator in the inflammatory response.Calcipotriol (hydrate) also induces expression of thymic stromal lymphopoietin, which triggers T-cell differentiation in keratinocytes.
Specification:
- Formal Name: 24-cyclopropyl-(1,3,5Z,7E,22E,24S)-9,10-secochola-5,7,10(19),22-tetraene-1,3,24-triol, monohydrate
- CAS Number :112828-00-9
- Synonyms : Calcipotriene
- Molecular Formula : C27H40O3 H2O
- Formula Weight :412.6
- Purity: 98%
- Formulation A crystalline solid
- Product Type: API
High Purity for Superior Clinical OutcomesCalcipotriol Monohydrate boasts a pharmaceutical-grade purity of 99%, ensuring that each batch delivers reliable results for psoriasis treatment. The micronized particle size enhances absorption and consistency in pharmaceutical formulations, thus promoting effective topical applications.
Optimal Storage and HandlingTo maintain potency, Calcipotriol Monohydrate should be stored in a cool, dry place away from light and moisture. This helps prevent degradation and ensures the APIs stability throughout its two-year shelf life, making it suitable for manufacturers and suppliers globally.
Safe and Efficient FormulationWith a loss on drying of 0.5% and heavy metal content not exceeding 10 ppm, Calcipotriol Monohydrate meets stringent pharmaceutical standards. It is odorless and non-poisonous, facilitating safe handling during formulation processes and guaranteeing quality output for dermatological therapies.
FAQs of Calcipotriol Monohydrate:
Q: How is Calcipotriol Monohydrate used in pharmaceutical products?
A: Calcipotriol Monohydrate serves as an active pharmaceutical ingredient primarily formulated into topical medications for the treatment of psoriasis. It is incorporated into creams, ointments, and solutions to help regulate skin cell production and alleviate symptoms.
Q: What benefits does Calcipotriol Monohydrate offer compared to other APIs?
A: Its high purity (99%) and micronized particle size ensure consistent efficacy and absorption. Additionally, it is odorless, non-poisonous, and complies with strict pharmaceutical regulations, making it a safe and effective option for topical therapies.
Q: When should Calcipotriol Monohydrate be stored and handled with special care?
A: During both storage and handling, Calcipotriol Monohydrate should be kept in a cool, dry environment and protected from light and moisture. These precautions ensure the stability and effectiveness of this pharmaceutical grade API throughout its shelf life.
Q: Where is Calcipotriol Monohydrate manufactured and exported from?
A: This API is manufactured, supplied, and exported by pharmaceutical companies based in India, adhering to international standards for purity and safety.
Q: What is the process of formulating Calcipotriol Monohydrate for topical use?
A: Calcipotriol Monohydrate is blended with suitable carriers, solvents, and stabilizers to create creams or ointments. Its micronized form allows for uniform distribution, while its solubility in ethanol and organic solvents aids in formulation.
Q: What is the main usage of Calcipotriol Monohydrate in dermatology?
A: Its primary use is in the management of psoriasis, where it helps normalize skin cell turnover, reducing scaling and inflammation associated with the condition.
Q: Is Calcipotriol Monohydrate safe for pharmaceutical applications?
A: Yes, it is considered safe when used as directed, with low loss on drying, minimal heavy metal content, and no poisonous components. Proper formulation and handling are crucial for optimal safety and efficacy.